Taiwan Reports Record Drug-Development Funds In First Half
This article was originally published in PharmAsia News
Executive Summary
Taiwan reports $86.6 million worth of investments in development of new drugs by its drug makers during the first half of this year, 18 times more than the same period a year ago. The Industry and Technology Intelligence Service said the pharmaceutical portion of the biotechnology industry also invested heavily, registering an investment level of $169.6, nearly half the investments in the overall biotech industry. The ITIS also reported strong growth in exports of biotech products, including biomedical materials and antibodies. (Click here for more